Skip to content

Schrodinger SDGR Equity Method Investments

Equity Method Investments at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$32.5M+0.6%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$31.52M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$209.72M-2.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$23.7M+3.0%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-41.8%
Enterprise value$984.71M-44.4%
P/S4.5×-4.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's equity method investments?
Schrodinger (SDGR) reported equity method investments of $39.83M in Q1 2026.
How has Schrodinger's equity method investments changed year-over-year?
Schrodinger's equity method investments increased by 32.3% year-over-year, from $30.11M to $39.83M.
What is the long-term trend for Schrodinger's equity method investments?
Over 5 years (2020 to 2025), Schrodinger's equity method investments has grown at a 10.0% compound annual growth rate (CAGR), from $45.66M to $73.65M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.